| 0 |
NTRK GENE FUSION OVEREXPRESSION |
1 |
0.5000 |
| 1 |
NASAL ASPIRATION |
1 |
0.2500 |
| 2 |
FIBROSARCOMA METASTATIC |
1 |
0.2000 |
| 3 |
UPPER AIRWAY NECROSIS |
1 |
0.1111 |
| 4 |
SALIVARY GLAND CANCER RECURRENT |
1 |
0.0909 |
| 5 |
ADENOCARCINOMA OF SALIVARY GLAND |
2 |
0.0769 |
| 6 |
NEUROENDOCRINE CARCINOMA OF PROSTATE |
1 |
0.0556 |
| 7 |
BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC |
1 |
0.0370 |
| 8 |
NEUROENDOCRINE TUMOUR OF THE LUNG METASTATIC |
1 |
0.0333 |
| 9 |
DESMOPLASTIC SMALL ROUND CELL TUMOUR |
2 |
0.0317 |
| 10 |
NERVOUS SYSTEM NEOPLASM |
1 |
0.0244 |
| 11 |
MENINGIOMA MALIGNANT |
1 |
0.0233 |
| 12 |
SALIVARY GLAND ADENOMA |
1 |
0.0208 |
| 13 |
LUNG SQUAMOUS CELL CARCINOMA METASTATIC |
1 |
0.0200 |
| 14 |
ANAPLASTIC THYROID CANCER |
1 |
0.0192 |
| 15 |
UTERINE LEIOMYOSARCOMA |
1 |
0.0154 |
| 16 |
VASCULAR NEOPLASM |
1 |
0.0130 |
| 17 |
OLIGODENDROGLIOMA |
1 |
0.0108 |
| 18 |
ASTROCYTOMA |
3 |
0.0106 |
| 19 |
MALIGNANT GLIOMA |
1 |
0.0103 |
| 20 |
GLIOMA |
4 |
0.0098 |
| 21 |
NON-SMALL CELL LUNG CANCER RECURRENT |
1 |
0.0085 |
| 22 |
SOFT TISSUE SARCOMA |
2 |
0.0080 |
| 23 |
HEAD CIRCUMFERENCE ABNORMAL |
1 |
0.0077 |
| 24 |
TRACHEAL HAEMORRHAGE |
2 |
0.0071 |
| 25 |
DOSE CALCULATION ERROR |
2 |
0.0066 |
| 26 |
SALIVARY GLAND PAIN |
1 |
0.0065 |
| 27 |
CHOLELITHOTOMY |
1 |
0.0063 |
| 28 |
GLIOBLASTOMA |
7 |
0.0062 |
| 29 |
PHARYNGEAL OPERATION |
1 |
0.0056 |
| 30 |
FOOD REFUSAL |
2 |
0.0052 |
| 31 |
SALIVARY GLAND CANCER |
2 |
0.0050 |
| 32 |
ALOPECIA UNIVERSALIS |
1 |
0.0048 |
| 33 |
THORACIC CAVITY DRAINAGE |
1 |
0.0047 |
| 34 |
PELVIC NEOPLASM |
1 |
0.0040 |
| 35 |
HEMIANAESTHESIA |
3 |
0.0038 |
| 36 |
INTRACRANIAL MASS |
2 |
0.0031 |
| 37 |
TUMOUR INVASION |
1 |
0.0029 |
| 38 |
METASTASES TO BONE MARROW |
1 |
0.0028 |
| 39 |
GLIOBLASTOMA MULTIFORME |
2 |
0.0028 |
| 40 |
ORTHOSTATIC HYPERTENSION |
1 |
0.0026 |
| 41 |
NEUROLOGICAL EXAMINATION ABNORMAL |
1 |
0.0026 |
| 42 |
NONINFECTIVE ENCEPHALITIS |
1 |
0.0026 |
| 43 |
REFUSAL OF TREATMENT BY RELATIVE |
1 |
0.0024 |
| 44 |
SARCOMA |
2 |
0.0023 |
| 45 |
LOSS OF THERAPEUTIC RESPONSE |
1 |
0.0023 |
| 46 |
INTERCEPTED PRODUCT ADMINISTRATION ERROR |
1 |
0.0022 |
| 47 |
METASTASES TO MENINGES |
3 |
0.0022 |
| 48 |
ALLODYNIA |
1 |
0.0020 |
| 49 |
TRAUMATIC FRACTURE |
1 |
0.0019 |
| 50 |
EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED |
1 |
0.0018 |
| 51 |
EYELID FUNCTION DISORDER |
1 |
0.0016 |
| 52 |
GENE MUTATION |
2 |
0.0016 |
| 53 |
BRONCHIAL CARCINOMA |
1 |
0.0015 |
| 54 |
EMERGENCY CARE |
2 |
0.0015 |
| 55 |
CARDIAC STRESS TEST ABNORMAL |
1 |
0.0014 |
| 56 |
HYPERVIGILANCE |
1 |
0.0013 |
| 57 |
LUNG CANCER METASTATIC |
3 |
0.0013 |
| 58 |
BONE NEOPLASM |
1 |
0.0012 |
| 59 |
COLORECTAL CANCER METASTATIC |
1 |
0.0011 |
| 60 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
1 |
0.0011 |
| 61 |
PANCREATIC NEOPLASM |
1 |
0.0011 |
| 62 |
TUMOUR PAIN |
1 |
0.0011 |
| 63 |
HAEMOLYTIC URAEMIC SYNDROME |
2 |
0.0010 |
| 64 |
GALLBLADDER CANCER |
1 |
0.0009 |
| 65 |
PANCREATIC CARCINOMA METASTATIC |
2 |
0.0009 |
| 66 |
COLON CANCER METASTATIC |
1 |
0.0008 |
| 67 |
SENSITIVE SKIN |
3 |
0.0008 |
| 68 |
THERAPEUTIC PRODUCT INEFFECTIVE |
2 |
0.0008 |
| 69 |
CARCINOEMBRYONIC ANTIGEN INCREASED |
1 |
0.0008 |
| 70 |
AMYLASE INCREASED |
2 |
0.0008 |
| 71 |
METASTASES TO LUNG |
6 |
0.0008 |
| 72 |
ALANINE AMINOTRANSFERASE ABNORMAL |
1 |
0.0007 |
| 73 |
CELL DEATH |
1 |
0.0007 |
| 74 |
EYELID IRRITATION |
1 |
0.0007 |
| 75 |
AMYOTROPHIC LATERAL SCLEROSIS |
1 |
0.0007 |
| 76 |
EAR HAEMORRHAGE |
1 |
0.0007 |
| 77 |
ENDOMETRIAL CANCER |
1 |
0.0006 |
| 78 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
1 |
0.0006 |
| 79 |
NEUROLOGICAL DECOMPENSATION |
1 |
0.0006 |
| 80 |
METASTASIS |
3 |
0.0006 |
| 81 |
PERIARTHRITIS |
1 |
0.0006 |
| 82 |
INCORRECT DOSAGE ADMINISTERED |
2 |
0.0006 |
| 83 |
JAW FRACTURE |
1 |
0.0006 |
| 84 |
VARICELLA |
1 |
0.0005 |
| 85 |
CEREBELLAR SYNDROME |
1 |
0.0005 |
| 86 |
HEPATIC CYTOLYSIS |
1 |
0.0005 |
| 87 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0005 |
| 88 |
ABDOMINAL MASS |
1 |
0.0005 |
| 89 |
DRUG RESISTANCE |
8 |
0.0005 |
| 90 |
METASTASES TO LYMPH NODES |
2 |
0.0004 |
| 91 |
ONYCHOMADESIS |
1 |
0.0004 |
| 92 |
SHOULDER OPERATION |
1 |
0.0004 |
| 93 |
FIBROSIS |
1 |
0.0004 |
| 94 |
SUSPECTED COUNTERFEIT PRODUCT |
1 |
0.0004 |
| 95 |
METASTASES TO LIVER |
5 |
0.0004 |
| 96 |
REGURGITATION |
1 |
0.0004 |
| 97 |
MULTIPLE ALLERGIES |
2 |
0.0004 |
| 98 |
THERAPY CHANGE |
2 |
0.0004 |
| 99 |
PRODUCT SUPPLY ISSUE |
1 |
0.0004 |
| 100 |
HALLUCINATIONS, MIXED |
1 |
0.0004 |
| 101 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
3 |
0.0004 |
| 102 |
NAIL DISCOLOURATION |
1 |
0.0004 |
| 103 |
HEPATIC LESION |
1 |
0.0003 |
| 104 |
METASTATIC NEOPLASM |
1 |
0.0003 |
| 105 |
TUMOUR MARKER INCREASED |
1 |
0.0003 |
| 106 |
SELF-INJURIOUS IDEATION |
1 |
0.0003 |
| 107 |
LIVER FUNCTION TEST INCREASED |
4 |
0.0003 |
| 108 |
DISEASE COMPLICATION |
1 |
0.0003 |
| 109 |
COMPRESSION FRACTURE |
1 |
0.0003 |
| 110 |
TRANSAMINASES INCREASED |
5 |
0.0003 |
| 111 |
HEPATIC ENZYME ABNORMAL |
1 |
0.0003 |
| 112 |
HYPERNATRAEMIA |
1 |
0.0003 |
| 113 |
NEUROTOXICITY |
3 |
0.0003 |
| 114 |
FAECALOMA |
1 |
0.0003 |
| 115 |
PULMONARY THROMBOSIS |
2 |
0.0003 |
| 116 |
PULMONARY TOXICITY |
1 |
0.0003 |
| 117 |
ASPERGILLUS INFECTION |
1 |
0.0003 |
| 118 |
CHOLANGITIS |
1 |
0.0002 |
| 119 |
HEPATOCELLULAR INJURY |
3 |
0.0002 |
| 120 |
HYDROCEPHALUS |
1 |
0.0002 |
| 121 |
NEURALGIA |
4 |
0.0002 |
| 122 |
PANCREATIC CARCINOMA |
5 |
0.0002 |
| 123 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 124 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0002 |
| 125 |
DISEASE PROGRESSION |
17 |
0.0002 |
| 126 |
MULTIPLE FRACTURES |
3 |
0.0002 |
| 127 |
FEELING OF BODY TEMPERATURE CHANGE |
1 |
0.0002 |
| 128 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0002 |
| 129 |
HYPERVENTILATION |
1 |
0.0002 |
| 130 |
DERMATITIS EXFOLIATIVE |
1 |
0.0002 |
| 131 |
POISONING DELIBERATE |
1 |
0.0002 |
| 132 |
THYROID CANCER |
2 |
0.0002 |
| 133 |
BRAIN OEDEMA |
2 |
0.0002 |
| 134 |
NEUROPATHY PERIPHERAL |
13 |
0.0002 |
| 135 |
TROPONIN INCREASED |
1 |
0.0002 |
| 136 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0002 |
| 137 |
METASTASES TO BONE |
2 |
0.0002 |
| 138 |
HAND FRACTURE |
1 |
0.0002 |
| 139 |
EYE MOVEMENT DISORDER |
1 |
0.0002 |
| 140 |
MYELOSUPPRESSION |
1 |
0.0002 |
| 141 |
PRE-EXISTING CONDITION IMPROVED |
1 |
0.0002 |
| 142 |
GAIT INABILITY |
3 |
0.0002 |
| 143 |
PNEUMOTHORAX |
2 |
0.0002 |
| 144 |
ESCHERICHIA INFECTION |
1 |
0.0002 |
| 145 |
HYPOAESTHESIA ORAL |
2 |
0.0002 |
| 146 |
PANIC REACTION |
1 |
0.0002 |
| 147 |
CARDIOMYOPATHY |
2 |
0.0002 |
| 148 |
SCRATCH |
1 |
0.0002 |
| 149 |
HEPATOCELLULAR CARCINOMA |
1 |
0.0002 |
| 150 |
FURUNCLE |
1 |
0.0002 |
| 151 |
PRODUCT USE COMPLAINT |
1 |
0.0002 |
| 152 |
DIZZINESS POSTURAL |
1 |
0.0002 |
| 153 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0002 |
| 154 |
HEPATIC ENZYME INCREASED |
7 |
0.0002 |
| 155 |
HEPATIC FUNCTION ABNORMAL |
4 |
0.0002 |
| 156 |
MUSCLE STRAIN |
1 |
0.0002 |
| 157 |
EMBOLISM |
1 |
0.0002 |
| 158 |
HYPERAESTHESIA |
1 |
0.0002 |
| 159 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
3 |
0.0001 |
| 160 |
THERAPY CESSATION |
5 |
0.0001 |
| 161 |
HYPERSOMNIA |
3 |
0.0001 |
| 162 |
RESTLESS LEGS SYNDROME |
2 |
0.0001 |
| 163 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
1 |
0.0001 |
| 164 |
OVARIAN CANCER |
1 |
0.0001 |
| 165 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
1 |
0.0001 |
| 166 |
HEPATIC ENCEPHALOPATHY |
1 |
0.0001 |
| 167 |
WITHDRAWAL SYNDROME |
4 |
0.0001 |
| 168 |
MOTOR DYSFUNCTION |
1 |
0.0001 |
| 169 |
NEOPLASM PROGRESSION |
3 |
0.0001 |
| 170 |
FEELING JITTERY |
2 |
0.0001 |
| 171 |
JOINT RANGE OF MOTION DECREASED |
1 |
0.0001 |
| 172 |
SPINAL PAIN |
1 |
0.0001 |
| 173 |
HOSPITALISATION |
12 |
0.0001 |
| 174 |
POLYNEUROPATHY |
1 |
0.0001 |
| 175 |
INTESTINAL PERFORATION |
1 |
0.0001 |
| 176 |
MALIGNANT NEOPLASM PROGRESSION |
8 |
0.0001 |
| 177 |
EAR INFECTION |
2 |
0.0001 |
| 178 |
LUNG DISORDER |
4 |
0.0001 |
| 179 |
PARAESTHESIA |
13 |
0.0001 |
| 180 |
SURGERY |
4 |
0.0001 |
| 181 |
TACHYPNOEA |
1 |
0.0001 |
| 182 |
NEOPLASM MALIGNANT |
5 |
0.0001 |
| 183 |
ALANINE AMINOTRANSFERASE INCREASED |
5 |
0.0001 |
| 184 |
PROSTATIC SPECIFIC ANTIGEN INCREASED |
1 |
0.0001 |
| 185 |
SKIN FISSURES |
1 |
0.0001 |
| 186 |
HYPERLIPIDAEMIA |
1 |
0.0001 |
| 187 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 188 |
ASPARTATE AMINOTRANSFERASE INCREASED |
4 |
0.0001 |
| 189 |
ORAL DISCOMFORT |
1 |
0.0001 |
| 190 |
FEELING COLD |
2 |
0.0001 |
| 191 |
CARDIOMEGALY |
1 |
0.0001 |
| 192 |
MASS |
1 |
0.0001 |
| 193 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 194 |
BLOOD BILIRUBIN INCREASED |
2 |
0.0001 |
| 195 |
INFLUENZA LIKE ILLNESS |
6 |
0.0001 |
| 196 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 197 |
ACUTE MYELOID LEUKAEMIA |
1 |
0.0001 |
| 198 |
DELUSION |
1 |
0.0001 |
| 199 |
ASCITES |
2 |
0.0001 |
| 200 |
RESPIRATORY DISORDER |
2 |
0.0001 |
| 201 |
LYMPHOMA |
1 |
0.0001 |
| 202 |
PAIN IN JAW |
2 |
0.0001 |
| 203 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0001 |
| 204 |
EJECTION FRACTION DECREASED |
1 |
0.0001 |
| 205 |
MYALGIA |
11 |
0.0001 |
| 206 |
OSTEOPENIA |
1 |
0.0001 |
| 207 |
THERAPY NON-RESPONDER |
2 |
0.0001 |
| 208 |
COORDINATION ABNORMAL |
1 |
0.0001 |
| 209 |
ERUCTATION |
1 |
0.0001 |
| 210 |
KNEE ARTHROPLASTY |
1 |
0.0001 |
| 211 |
INCREASED APPETITE |
1 |
0.0001 |
| 212 |
HYPOAESTHESIA |
9 |
0.0001 |
| 213 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 214 |
FULL BLOOD COUNT DECREASED |
1 |
0.0001 |
| 215 |
ACCIDENTAL OVERDOSE |
2 |
0.0001 |
| 216 |
FLUID RETENTION |
3 |
0.0001 |
| 217 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 218 |
HERNIA |
1 |
0.0001 |
| 219 |
NERVOUS SYSTEM DISORDER |
2 |
0.0001 |
| 220 |
GOUT |
1 |
0.0001 |
| 221 |
ILLNESS |
2 |
0.0001 |
| 222 |
PRODUCT DOSE OMISSION |
5 |
0.0001 |
| 223 |
PSYCHOMOTOR HYPERACTIVITY |
1 |
0.0001 |
| 224 |
DIZZINESS |
27 |
0.0001 |
| 225 |
CHOKING |
1 |
0.0001 |
| 226 |
CHOLESTASIS |
1 |
0.0001 |
| 227 |
SINUS DISORDER |
1 |
0.0001 |
| 228 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 229 |
HEPATOTOXICITY |
1 |
0.0001 |
| 230 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 231 |
PLEURAL EFFUSION |
3 |
0.0001 |
| 232 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 233 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
0.0001 |
| 234 |
MENTAL DISORDER |
2 |
0.0001 |
| 235 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
0.0001 |
| 236 |
LUNG NEOPLASM MALIGNANT |
2 |
0.0001 |
| 237 |
PERIPHERAL SWELLING |
6 |
0.0001 |
| 238 |
PRODUCT DOSE OMISSION ISSUE |
5 |
0.0001 |
| 239 |
DISEASE RECURRENCE |
1 |
0.0001 |
| 240 |
COGNITIVE DISORDER |
2 |
0.0001 |
| 241 |
WOUND |
1 |
0.0001 |
| 242 |
RESPIRATORY TRACT INFECTION |
1 |
0.0001 |
| 243 |
MELAENA |
1 |
0.0001 |
| 244 |
ENCEPHALOPATHY |
1 |
0.0001 |
| 245 |
CHROMATURIA |
1 |
0.0001 |
| 246 |
PNEUMONITIS |
1 |
0.0001 |
| 247 |
CONSTIPATION |
8 |
0.0001 |
| 248 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0001 |
| 249 |
BONE MARROW FAILURE |
1 |
0.0001 |
| 250 |
DYSGEUSIA |
3 |
0.0001 |
| 251 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0001 |
| 252 |
PNEUMONIA ASPIRATION |
1 |
0.0001 |
| 253 |
HAEMATOCHEZIA |
2 |
0.0001 |
| 254 |
BREAST CANCER FEMALE |
1 |
0.0001 |
| 255 |
ABDOMINAL DISTENSION |
4 |
0.0001 |
| 256 |
RESPIRATORY FAILURE |
3 |
0.0001 |
| 257 |
DISCOMFORT |
2 |
0.0001 |
| 258 |
HEPATITIS |
1 |
0.0001 |
| 259 |
BLISTER |
2 |
0.0001 |
| 260 |
RENAL IMPAIRMENT |
3 |
0.0001 |
| 261 |
OEDEMA |
2 |
0.0001 |
| 262 |
LOSS OF CONSCIOUSNESS |
5 |
0.0001 |
| 263 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
0.0001 |
| 264 |
WEIGHT INCREASED |
8 |
0.0001 |
| 265 |
SPEECH DISORDER |
2 |
0.0001 |
| 266 |
PAIN |
23 |
0.0001 |
| 267 |
COVID-19 |
2 |
0.0001 |
| 268 |
NECK PAIN |
2 |
0.0000 |
| 269 |
CONFUSIONAL STATE |
6 |
0.0000 |
| 270 |
ANAEMIA |
7 |
0.0000 |
| 271 |
OSTEONECROSIS OF JAW |
1 |
0.0000 |
| 272 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 273 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 274 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 275 |
LETHARGY |
2 |
0.0000 |
| 276 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 277 |
DYSSTASIA |
1 |
0.0000 |
| 278 |
JAUNDICE |
1 |
0.0000 |
| 279 |
FATIGUE |
24 |
0.0000 |
| 280 |
HEAD INJURY |
1 |
0.0000 |
| 281 |
APHASIA |
1 |
0.0000 |
| 282 |
GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0000 |
| 283 |
GAIT DISTURBANCE |
6 |
0.0000 |
| 284 |
HEPATIC FAILURE |
1 |
0.0000 |
| 285 |
IRRITABILITY |
2 |
0.0000 |
| 286 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 287 |
URINARY RETENTION |
1 |
0.0000 |
| 288 |
HYPOXIA |
1 |
0.0000 |
| 289 |
FEMUR FRACTURE |
1 |
0.0000 |
| 290 |
PYREXIA |
10 |
0.0000 |
| 291 |
HYPERKALAEMIA |
1 |
0.0000 |
| 292 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 293 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 294 |
BURNING SENSATION |
2 |
0.0000 |
| 295 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 296 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 297 |
JOINT SWELLING |
3 |
0.0000 |
| 298 |
OFF LABEL USE |
17 |
0.0000 |
| 299 |
HAEMATURIA |
1 |
0.0000 |
| 300 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 301 |
NEUTROPENIA |
3 |
0.0000 |
| 302 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 303 |
DYSURIA |
1 |
0.0000 |
| 304 |
ABDOMINAL PAIN UPPER |
5 |
0.0000 |
| 305 |
HYPOTENSION |
5 |
0.0000 |
| 306 |
NAUSEA |
19 |
0.0000 |
| 307 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 308 |
THROMBOSIS |
2 |
0.0000 |
| 309 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 310 |
ARTHRALGIA |
9 |
0.0000 |
| 311 |
MUSCULOSKELETAL STIFFNESS |
2 |
0.0000 |
| 312 |
LIVER DISORDER |
1 |
0.0000 |
| 313 |
VOMITING |
11 |
0.0000 |
| 314 |
THROAT IRRITATION |
1 |
0.0000 |
| 315 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 316 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 317 |
PAIN IN EXTREMITY |
7 |
0.0000 |
| 318 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 319 |
SWELLING |
2 |
0.0000 |
| 320 |
ANGIOEDEMA |
1 |
0.0000 |
| 321 |
BALANCE DISORDER |
2 |
0.0000 |
| 322 |
OEDEMA PERIPHERAL |
3 |
0.0000 |
| 323 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 324 |
DYSPHAGIA |
2 |
0.0000 |
| 325 |
MUSCLE SPASMS |
4 |
0.0000 |
| 326 |
ASTHMA |
2 |
0.0000 |
| 327 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 328 |
TINNITUS |
1 |
0.0000 |
| 329 |
RENAL DISORDER |
1 |
0.0000 |
| 330 |
DYSPEPSIA |
2 |
0.0000 |
| 331 |
FALL |
7 |
0.0000 |
| 332 |
CARDIAC FAILURE CONGESTIVE |
2 |
0.0000 |
| 333 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 334 |
EYE PAIN |
1 |
0.0000 |
| 335 |
COMA |
1 |
0.0000 |
| 336 |
SEIZURE |
2 |
0.0000 |
| 337 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
0.0000 |
| 338 |
SKIN IRRITATION |
1 |
0.0000 |
| 339 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 340 |
LEUKOPENIA |
1 |
0.0000 |
| 341 |
COUGH |
5 |
0.0000 |
| 342 |
DEPRESSED MOOD |
1 |
0.0000 |
| 343 |
CELLULITIS |
1 |
0.0000 |
| 344 |
PULMONARY EMBOLISM |
2 |
0.0000 |
| 345 |
DECREASED APPETITE |
4 |
0.0000 |
| 346 |
THROMBOCYTOPENIA |
2 |
0.0000 |
| 347 |
PANCYTOPENIA |
1 |
0.0000 |
| 348 |
DRUG WITHDRAWAL SYNDROME |
2 |
0.0000 |
| 349 |
INCORRECT DOSE ADMINISTERED |
3 |
0.0000 |
| 350 |
FLATULENCE |
1 |
0.0000 |
| 351 |
SEPSIS |
2 |
0.0000 |
| 352 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 353 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 354 |
ABDOMINAL PAIN |
4 |
0.0000 |
| 355 |
DYSPNOEA |
10 |
0.0000 |
| 356 |
DEATH |
14 |
0.0000 |
| 357 |
COLORECTAL CANCER |
1 |
0.0000 |
| 358 |
FEELING HOT |
1 |
0.0000 |
| 359 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 360 |
PRODUCT USE IN UNAPPROVED INDICATION |
3 |
0.0000 |
| 361 |
CEREBROVASCULAR ACCIDENT |
3 |
0.0000 |
| 362 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 363 |
VERTIGO |
1 |
0.0000 |
| 364 |
SOMNOLENCE |
3 |
0.0000 |
| 365 |
DRUG INEFFECTIVE |
19 |
0.0000 |
| 366 |
HOT FLUSH |
1 |
0.0000 |
| 367 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 368 |
AMNESIA |
1 |
0.0000 |
| 369 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 370 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 371 |
TREATMENT FAILURE |
1 |
0.0000 |
| 372 |
ASTHENIA |
5 |
0.0000 |
| 373 |
DIARRHOEA |
8 |
0.0000 |
| 374 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 375 |
PNEUMONIA |
4 |
0.0000 |
| 376 |
TOXICITY TO VARIOUS AGENTS |
2 |
0.0000 |
| 377 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 378 |
URTICARIA |
2 |
0.0000 |
| 379 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 380 |
RASH |
5 |
0.0000 |
| 381 |
CONDITION AGGRAVATED |
3 |
0.0000 |
| 382 |
FEELING ABNORMAL |
3 |
0.0000 |
| 383 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 384 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
0.0000 |
| 385 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 386 |
TREMOR |
2 |
0.0000 |
| 387 |
WEIGHT DECREASED |
3 |
0.0000 |
| 388 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 389 |
ADVERSE EVENT |
1 |
0.0000 |
| 390 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 391 |
HEART RATE INCREASED |
1 |
0.0000 |
| 392 |
CHEST PAIN |
2 |
0.0000 |
| 393 |
SINUSITIS |
1 |
0.0000 |
| 394 |
ALOPECIA |
2 |
0.0000 |
| 395 |
HAEMORRHAGE |
1 |
0.0000 |
| 396 |
FLUSHING |
1 |
0.0000 |
| 397 |
BREAST CANCER |
1 |
0.0000 |
| 398 |
CHILLS |
1 |
0.0000 |
| 399 |
INFECTION |
1 |
0.0000 |
| 400 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 401 |
INSOMNIA |
2 |
0.0000 |
| 402 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 403 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 404 |
MALAISE |
3 |
0.0000 |
| 405 |
HEADACHE |
4 |
0.0000 |
| 406 |
DRUG INTERACTION |
1 |
0.0000 |
| 407 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 408 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 409 |
OVERDOSE |
1 |
0.0000 |
| 410 |
BACK PAIN |
1 |
0.0000 |
| 411 |
PRURITUS |
1 |
0.0000 |